Log in to save to my catalogue

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9098186

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The disialoganglioside GD2 is overexpressed on several solid tumors, and monoclonal antibodies targeting GD2 have substantially improved outcomes for children with high-risk neuroblastoma. However, approximately 40% of patients with neuroblastoma still relapse, and anti-GD2 has not mediated significant clinical activity in any other GD2
+
mal...

Alternative Titles

Full title

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9098186

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9098186

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-021-01625-x

How to access this item